1.07 CME

Tobacco Deaddiction Therapies

Speaker: Dr. Nilam Gada

Speaker, Head Office of Indian Dental Association, Mumbai

Login to Start

Description

"Tobacco Deaddiction Therapies" is a comprehensive webinar aimed at exploring effective strategies for helping individuals overcome tobacco dependence. The session will cover both conventional and alternative approaches, including behavioral therapies, pharmacological interventions, and AYUSH-based methods like Ayurveda, Yoga, and Naturopathy. It will also address the psychological, physiological, and social dimensions of tobacco addiction, offering a holistic framework for treatment. Designed for healthcare professionals, this session will provide practical insights and protocols to enhance success rates in tobacco deaddiction efforts.

Summary Listen

  • Tobacco de-addiction is challenging due to its bio-psychosocial nature, encompassing physical, psychological, and social factors. India faces a significant burden with high rates of smokeless tobacco consumption and oral cancers, leading to substantial healthcare costs. Tobacco is a leading preventable cause of death and disability globally, with 50% of users facing premature mortality.
  • The WHO's 5A (Ask, Assess, Advise, Assist, Arrange) and 5R (Relevance, Risks, Rewards, Roadblocks, Repetition) approaches guide tobacco cessation. The 5A approach is used when the patient is willing to quit. The 5R approach is used when the patient is not willing to quit. Ask involves detailed patient history, while Assess uses the Fagerström test (or modified version for smokeless tobacco) to determine nicotine dependence levels.
  • Advise focuses on personalized motivation, linking quitting to individual concerns like health, finances, or family well-being. Assist entails setting a quit date, informing support networks, and removing tobacco-related cues. Arrange emphasizes follow-up appointments at 1, 2, 4, and 6 weeks, with ongoing support and quit line resources.
  • Treatment includes counseling (behavioral interventions, cognitive behavioral therapy, and motivational interviewing), pharmacological options (Nicotine Replacement Therapy - NRT, and prescription medicines), and newer advancements like support groups and apps. Counseling alone can help 80% of patients quit, while 15% may need NRT and 5% may require pharmaceutical interventions.
  • Motivational interviewing focuses on a collaborative conversation to navigate the patient to the need to quit. Instead of convincing him to change, extracting something from the patient.
  • NRT provides nicotine without the harmful chemicals in tobacco, available as patches, sprays, gums, lozenges, and inhalers. Patches offer long-acting relief, while other forms address immediate cravings. Dosage depends on the level of nicotine dependence.
  • Pharmaceutical medicines like bupropion and varenicline can be used when NRT is unsuitable or ineffective. These medicines control neurotransmitters and nicotine receptors.
  • Effective coping mechanisms are crucial for managing cravings, withdrawal symptoms, and trigger factors. Cravings are temporary urges that last around 20 minutes and can be managed through deep breathing, distraction, and dietary changes.
  • Withdrawal symptoms can include anxiety, irritability, and difficulty concentrating, peaking within the first 10 days. Trigger factors related to time, place, or person must be identified and addressed. Combination therapy, involving counseling, NRT, and medication, yields better results.
  • Collaboration, quit lines, support groups like Nicotine Anonymous, and lifestyle changes are important for successful tobacco cessation. Newer treatments like deep TMS (Transcranial Magnetic Stimulation) show promise by targeting brain areas involved in addiction.

Comments